Stay updated on SBRT ± Nivolumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SBRT ± Nivolumab in NSCLC Clinical Trial page.

Latest updates to the SBRT ± Nivolumab in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRecruitment status changed to No longer looking for participants, and new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention heading was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment' and the revision note updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check20 days agoChange DetectedA revision label on the page was updated from v3.5.4 to v3.5.5, indicating a backend or content management system update for the entry.SummaryDifference0.1%

- Check42 days agoChange DetectedThe revision tag on the page was updated from v3.5.3 to v3.5.4, indicating a new version of the page. It does not modify the study content or how the page is presented.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page’s software/document revision indicator was updated from v3.5.2 to v3.5.3, reflecting a backend/version change rather than a modification to the study record content.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded page revision details for v3.5.2 with April 2026 dates and removed references to v3.5.0.SummaryDifference0.3%

- Check99 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3. This update appears to modify internal versioning information and does not change displayed content.SummaryDifference0.1%

Stay in the know with updates to SBRT ± Nivolumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT ± Nivolumab in NSCLC Clinical Trial page.